N-(4-{6-oxo-5,12,14-trioxa-2-azatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),3(7),10,15-tetraen-8-yl}phenyl)acetamide

Catalog No. :
ACNPVH334
CAS No. :
866050-84-2
Molecular Formula :
C20H16N2O5
Molecular Weight :
364.36

IUPAC Name:N-(4-(8-oxo-5,6,8,9-tetrahydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-9-yl)phenyl)acetamide

N-(4-{6-oxo-5,12,14-trioxa-2-azatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),3(7),10,15-tetraen-8-yl}phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-{6-oxo-5,12,14-trioxa-2-azatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),3(7),10,15-tetraen-8-yl}phenyl)acetamide
IUPAC NameN-(4-(8-oxo-5,6,8,9-tetrahydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-9-yl)phenyl)acetamide
Molecular FormulaC20H16N2O5
Molecular Weight364.36
SMILESCC(NC1=CC=C(C2C3=C(COC3=O)NC4=C2C=C5C(OCO5)=C4)C=C1)=O
InChI KeyAARPPPBECMREOJ-UHFFFAOYSA-N
SynonymN-[4-(8-OXO-5,6,8,9-TETRAHYDRO[1,3]DIOXOLO[4,5-G]FURO[3,4-B]QUINOLIN-9-YL)PHENYL]ACETAMIDE;N-(4-{6-oxo-5,12,14-trioxa-2-azatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),3(7),10,15-tetraen-8-yl}phenyl)acetamide;Acetamide, N-[4-(5,6,8,9-tetrahydro-8-oxo-1,3-dioxolo[4,5-g]furo[3,4-b]quinolin-9-yl)phenyl]-
CAS No.866050-84-2

Synthetic Route by SureRoute

1. ACNPVH334 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNPVH334 route product structure diagram
    ACNPVH334866050-84-2
Inquiry

2. ACNPVH334 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNPVH334 route product structure diagram
    ACNPVH334866050-84-2
Inquiry

Comments (0)